The purpose of this study was to determine the validity of the Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Self-Assessment Tool (OST) chart and equation, and a criterion based on body weight for identifying women with asymptomatic primary osteoporosis. Prospective recruitment and chart abstractions from family practices of three University affiliated hospitals were completed for women aged 45 years or more with baseline bone mineral density (BMD) testing results by dual energy X-ray absorptiometry. Those taking bone active medication other than hormone therapy, with prior fragility fracture or with risk factors for secondary osteoporosis were excluded. Women were categorized as being normal, osteopenic or osteoporotic by lowest BMD T-score at either the femoral neck or lumbar spine (L1-L4). Sensitivity, specificity and area under the receiver operating characteristic (ROC) curve to identify those with osteoporosis were determined for each decision rule. The positive predictive value (PPV) for detecting osteoporosis after using a second cut point to convert each decision rule into a risk index (low, moderate or high risk) was also determined. The sensitivity of the decision rules to identify women with osteoporosis ranged from 92% to 95% and specificity from 35% to 46%. The area under the ROC curves were significantly better for the ORAI (0.80), OST chart (0.82) and OST equation (0.82) compared with the body weight criterion (0.73). PPV for detecting osteoporosis ranged from 30% to 58% among women deemed at high risk. These data confirm the validity of the ORAI, the OST chart and the OST equation as screening tools for BMD testing. Further evidence is required to confirm the validity of the body weight criterion.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00198-003-1552-7DOI Listing

Publication Analysis

Top Keywords

ost chart
12
body weight
12
osteoporosis
9
decision rules
8
primary osteoporosis
8
bone mineral
8
mineral density
8
bmd testing
8
decision rule
8
ppv detecting
8

Similar Publications

Article Synopsis
  • HCV treatment has significantly improved with direct-acting antiviral therapy (DAA), allowing for shorter treatment durations and better tolerability in difficult-to-treat populations, such as people who inject drugs (PWID) and those on opioid substitution therapy (OST).
  • A retrospective analysis of patients receiving DAA at a clinic in Bonn showed that all patients on glecaprevir/pibrentasvir completed their treatment, while 86% of those on sofosbuvir/velpatasvir did, resulting in a 74% sustained virological response (SVR) overall, despite some patients being lost to follow-up.
  • The study highlights high adherence and SVR rates for HCV treatment in PWID, supporting efforts to
View Article and Find Full Text PDF

Background: Women who use or are in treatment for drug use during the perinatal period often have complex needs and presenting comorbidity. Women who use opioids during pregnancy, and their infants, experience poor outcomes. Drug use by women during pregnancy is a public health priority.

View Article and Find Full Text PDF
Article Synopsis
  • Primary cutaneous anaplastic large-cell lymphomas (pcALCLs) are a form of cutaneous T-cell lymphoma that consistently express CD30, unlike mycosis fungoides (MF), which shows varied expression.
  • In a study called ALCANZA, patients with pcALCLs or CD30-positive MF treated with brentuximab vedotin (BV) had better outcomes in terms of response rates and longer survival compared to those receiving other standard therapies like methotrexate or bexarotene.
  • The analysis found that in a real-world setting, patients treated with BV showed significantly improved treatment duration, response rates, progression-free survival, and healthcare resource use compared to those receiving other
View Article and Find Full Text PDF

Introduction: Individuals with dementia spend most of the day without care, without encounters, and usually without activity. Although this has been proven in studies, there is a knowledge gap on how individuals with dementia experience these periods of time. Such knowledge would be highly relevant for health professionals and relatives to develop adequate strategies for dealing with these periods of time.

View Article and Find Full Text PDF

Osteoporosis is commonly referred to as the "silent disease," as bone loss is gradual and asymptomatic. In older women and men, osteoporosis can lead to increased bone fragility, thus increasing the risk of fractures. These fractures are associated with healthcare costs, physical disabilities, impaired quality of life, and mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!